Increased risk of secondary cancers in patients with breast cancer under age 50 and the identification of non-BRCA inherited cancer syndromes using multi-gene hereditary cancer panels

被引：0
|
作者：
Diab, S.
Stuenke, A.
Kagey, J.
Hamlington, B.
Keiles, S.
Freivogel, M.
Asmar, L.
Langer, L.
机构：
[1] Rocky Mt Canc Ctr, Aurora, CO USA
[2] Rocky Mt Canc Ctr, Denver, CO USA
[3] US Oncol Res, The Woodlands, TX USA
[4] Genet Risk Evaluat & Testing Program GREAT, The Woodlands, TX USA
[5] Ambry Genet, Aliso Viejo, CA USA
[6] Compass Oncol, Portland, OR USA
[7] Invis Sally Jobe, Englewood, CO USA
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P3-07-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-07-02
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Germline variants in high-risk non-BRCA breast cancer patients from Puerto Rico
    Dutil, Julie
    Teer, Jamie K.
    Golubeva, Volha
    Yoder, Sean
    Arroyo, Nelly
    Echenique, Miguel
    Matta, Jaime
    Monteiro, Alvaro
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 149 - 149
  • [32] Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-gene Panels: Beyond BRCA1/2
    Eoh, Kyung Jin
    Kim, Ji Eun
    Park, Hyung Seok
    Lee, Seung-Tae
    Park, Ji Soo
    Han, Jung Woo
    Lee, Jung-Yun
    Kim, Sunghoon
    Kim, Sang Wun
    Kim, Jae Hoon
    Kim, Young Tae
    Nam, Eun Ji
    CANCER RESEARCH AND TREATMENT, 2018, 50 (03): : 917 - 925
  • [33] Increased access to TP53 analysis through breast cancer multi-gene panels: clinical considerations
    Azzollini, Jacopo
    Mariani, Milena
    Peissel, Bernard
    Manoukian, Siranoush
    FAMILIAL CANCER, 2018, 17 (03) : 317 - 319
  • [34] Value of germline multi-gene panel next generation sequencing (NGS) in identification of hereditary cancer syndromes (HCS) in colorectal cancer population (CRC)
    Gu, Jing
    Ricker, Charite
    Barzi, Afsaneh
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] Increased access to TP53 analysis through breast cancer multi-gene panels: clinical considerations
    Jacopo Azzollini
    Milena Mariani
    Bernard Peissel
    Siranoush Manoukian
    Familial Cancer, 2018, 17 : 317 - 319
  • [36] Development and validation of a residual risk score to predict breast cancer risk in unaffected women negative for mutations on a multi-gene hereditary cancer panel
    Hughes, Elisha
    Judkins, Thaddeus
    Wagner, Susanne
    Wenstrup, Richard J.
    Lanchbury, Jerry S.
    Gutin, Alexander
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [37] Clinicopathological Features of Breast Cancer in 149 Patients with Non-BRCA Gene Mutations: A Single Institutional Cohort Study
    Yu, Qing
    Heller, Melissa
    Mehr, Chelsea
    LABORATORY INVESTIGATION, 2025, 105 (03)
  • [38] Increased identification of patients at risk for hereditary colorectal cancer using a questionnaire.
    Monteith, T
    Bostick, R
    Brooks, K
    Seabrook, M
    Young, SR
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 238 - 238
  • [39] Role of the multi-gene panel testing for detection of pathogenic variants in patients with hereditary bilateral breast cancer
    Filorizzo, C.
    Fanale, D.
    Incorvaia, L.
    Barraco, N.
    Bono, M.
    Brando, C.
    Calo, V.
    Cancelliere, D.
    Cucinella, A.
    Dimino, A.
    Fiorino, A.
    Magrin, L.
    Pedone, E.
    Perez, A.
    Pivetti, A.
    Sammataro, S.
    Sciacchitano, R.
    Vaccaro, G.
    Bazan, V.
    Russo, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S432 - S433
  • [40] PREVALENCE OF GENE MUTATIONS IN PATIENTS AT INCREASED RISK OF PANCREATIC CANCER: IMPACT OF MULTI-GENE PANEL TESTING
    Zhu, Huili
    Welinsky, Sara
    Soper, Emily
    Abul-Husn, Noura S.
    Lucas, Aimee L.
    GASTROENTEROLOGY, 2019, 156 (06) : S1086 - S1086
12345